{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:29:10Z","timestamp":1790562550684,"version":"4.1.0"},"reference-count":151,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T00:00:00Z","timestamp":1503014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Platelets play a fundamental role in normal hemostasis, while their inherited or acquired dysfunctions are involved in a variety of bleeding disorders or thrombotic events. Several laboratory methodologies or point-of-care testing methods are currently available for clinical and experimental settings. These methods describe different aspects of platelet function based on platelet aggregation, platelet adhesion, the viscoelastic properties during clot formation, the evaluation of thromboxane metabolism or certain flow cytometry techniques. Platelet aggregometry is applied in different clinical settings as monitoring response to antiplatelet therapies, the assessment of perioperative bleeding risk, the diagnosis of inherited bleeding disorders or in transfusion medicine. The rationale for platelet function-driven antiplatelet therapy was based on the result of several studies on patients undergoing percutaneous coronary intervention (PCI), where an association between high platelet reactivity despite P2Y12 inhibition and ischemic events as stent thrombosis or cardiovascular death was found. However, recent large scale randomized, controlled trials have consistently failed to demonstrate a benefit of personalised antiplatelet therapy based on platelet function testing.<\/jats:p>","DOI":"10.3390\/ijms18081803","type":"journal-article","created":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T04:12:17Z","timestamp":1503288737000},"page":"1803","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Platelet Aggregometry Testing: Molecular Mechanisms, Techniques and Clinical Implications"],"prefix":"10.3390","volume":"18","author":[{"given":"Katalin","family":"Koltai","sequence":"first","affiliation":[{"name":"First Department of Medicine, University of Pecs, Pecs 7624, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8444-3818","authenticated-orcid":false,"given":"Gabor","family":"Kesmarky","sequence":"additional","affiliation":[{"name":"First Department of Medicine, University of Pecs, Pecs 7624, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"Feher","sequence":"additional","affiliation":[{"name":"Hospital of Szigetvar, Szigetvar 7900, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antal","family":"Tibold","sequence":"additional","affiliation":[{"name":"Department of Public Health Medicine, University of Pecs, Pecs 7624, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0114-5231","authenticated-orcid":false,"given":"Kalman","family":"Toth","sequence":"additional","affiliation":[{"name":"First Department of Medicine, University of Pecs, Pecs 7624, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,8,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1538-7836.2009.03455.x","article-title":"Calcium signaling in platelets","volume":"7","author":"Braun","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/ATVBAHA.107.150474","article-title":"Cell adhesion mechanisms in platelets","volume":"28","author":"Pleines","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/j.1538-7836.2006.02192.x","article-title":"Nucleotide receptor signaling in platelets","volume":"4","author":"Kahner","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12265-013-9529-1","article-title":"Antiplatelet therapy: Targeting the TxA2 pathway","volume":"7","author":"Fontana","year":"2014","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1055\/s-0037-1616218","article-title":"Cytoskeletal proteins and platelet signaling","volume":"86","author":"Fox","year":"2001","journal-title":"Thromb. Haemost."},{"key":"ref_6","first-page":"207","article-title":"Arrangements of actin filaments in the cytoskeleton of human platelets","volume":"117","author":"White","year":"1984","journal-title":"Am. J. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1016\/S0021-9258(17)42774-8","article-title":"Evidence for a role of myosin phosphorylation in the initiation of the platelet shape change response","volume":"259","author":"Daniel","year":"1984","journal-title":"J. Biol. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1016\/S0021-9258(19)69080-0","article-title":"Changes in the cytoskeletal structure of human platelets following thrombin activation","volume":"256","author":"Jennings","year":"1981","journal-title":"J. Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1073\/pnas.0400742101","article-title":"Membrane-mediated structural transitions at the cytoplasmic face during integrin activation","volume":"101","author":"Vinogradova","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/bip.22679","article-title":"Regulation of integrins in platelets","volume":"104","author":"Bennett","year":"2015","journal-title":"Biopolymers"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kauskot, A., and Hoylaerts, M.F. (2012). Platelet receptors. Handb. Exp. Pharmacol., 23\u201357.","DOI":"10.1007\/978-3-642-29423-5_2"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/10739680802651477","article-title":"Platelet adhesion under flow","volume":"16","author":"Ruggeri","year":"2009","journal-title":"Microcirculation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1081\/RRS-120034252","article-title":"Signaling pathways of the F11 receptor (F11R; a.k.a. JAM-1, JAM-A) in human platelets: F11R dimerization, phosphorylation and complex formation with the integrin GPIIIa","volume":"24","author":"Sobocka","year":"2004","journal-title":"J. Recept. Signal. Transduct. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1182\/blood-2005-01-0333","article-title":"Platelet aggregation induces platelet aggregate stability via SLAM family receptor signaling","volume":"106","author":"Nanda","year":"2005","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1182\/blood-2013-04-496232","article-title":"Junctional adhesion molecule-A suppresses platelet integrin \u03b1IIb\u03b23 signaling by recruiting Csk to the integrin-c-Src complex","volume":"123","author":"Naik","year":"2014","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Rumbaut, R.E., and Thiagarajan, P. (2010). Platelet-Vessel Wall Interactions in Hemostasis and Thrombosis, Morgan & Claypool Life Sciences.","DOI":"10.4199\/C00007ED1V01Y201002ISP004"},{"key":"ref_17","unstructured":"Michelson, A.D. (2007). Thromboxane Generation. Platelets, Elsevier\/Academic Press."},{"key":"ref_18","first-page":"217","article-title":"Pharmacology of thromboxane A2, prostacyclin and other eicosanoids in the cardiovascular system","volume":"46","year":"1991","journal-title":"Therapie"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4N","DOI":"10.1016\/j.amjcard.2006.09.008","article-title":"Current options in platelet function testing","volume":"98","author":"Michelson","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1592\/phco.23.5.579.32206","article-title":"Aspirin dosage and thromboxane synthesis in patients with vascular disease","volume":"23","author":"Hart","year":"2003","journal-title":"Pharmacotherapy"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.thromres.2008.12.034","article-title":"Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration","volume":"124","author":"Hedegaard","year":"2009","journal-title":"Thromb. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1253\/circj.CJ-12-1421","article-title":"Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction","volume":"77","author":"DeFilippis","year":"2013","journal-title":"Circ. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.carrev.2010.09.005","article-title":"Currently available methods for platelet function analysis: Advantages and disadvantages","volume":"12","author":"Pakala","year":"2011","journal-title":"Cardiovasc. Revasc. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000350469","article-title":"State of the art in platelet function testing","volume":"40","author":"Kehrel","year":"2013","journal-title":"Transfus. Med. Hemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/FJC.0b013e31818eee5f","article-title":"Aspirin resistance: Focus on clinical endpoints","volume":"52","author":"Pusch","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2008.01105.x","article-title":"The genetics of antiplatelet drug resistance","volume":"75","author":"Feher","year":"2009","journal-title":"Clin. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/01.ATV.0000145980.39477.a9","article-title":"Aspirin and clopidogrel: Efficacy, safety, and the issue of drug resistance","volume":"24","author":"Cattaneo","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/hrt.2008.150631","article-title":"Assessment of aspirin resistance varies on a temporal basis in patients with ischaemic heart disease","volume":"95","author":"Muir","year":"2009","journal-title":"Heart"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"630","DOI":"10.5551\/jat.17665","article-title":"Differential impact of inflammation on six laboratory assays measuring residual arachidonic acid-inducible platelet reactivity during dual antiplatelet therapy","volume":"20","author":"Gremmel","year":"2013","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"11585","DOI":"10.1016\/S0021-9258(18)67283-7","article-title":"Monoclonal antibodies to thromboxane synthase from porcine lung. Production and application to development of a tandem immunoradiometric assay","volume":"261","author":"Shen","year":"1986","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0005-2760(87)90233-5","article-title":"Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine","volume":"918","author":"Ciabattoni","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0049-3848(88)90118-1","article-title":"Radioimmunoassay of thromboxane B2 in plasma: Methodological modifications","volume":"51","author":"Rogasi","year":"1988","journal-title":"Thromb. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(06)68040-9","article-title":"Aspirin resistance","volume":"367","author":"Hankey","year":"2006","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"I10","DOI":"10.1002\/clc.20361","article-title":"Assessing the current role of platelet function testing","volume":"31","author":"Braunwald","year":"2008","journal-title":"Clin. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000214846","article-title":"Laboratory diagnosis and molecular classification of von Willebrand disease","volume":"121","author":"Gadisseur","year":"2009","journal-title":"Acta Haematol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1538-7836.2009.03273.x","article-title":"Diagnostic utility of light transmission platelet aggregometry: Results from a prospective study of individuals referred for bleeding disorder assessments","volume":"7","author":"Hayward","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1309\/AJCP9V3RRVNZMKDS","article-title":"Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry","volume":"134","author":"Hayward","year":"2010","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09537100701771736","article-title":"Lack of reproducibility of assessment of aspirin responsiveness by optical aggregometry and two platelet function tests","volume":"19","author":"Harrison","year":"2008","journal-title":"Platelets"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/1076029611418961","article-title":"Good short-term but not long-term reproducibility of the antiplatelet efficacy laboratory assessment","volume":"18","author":"Sevcikova","year":"2012","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2141.2009.07890.x","article-title":"Diagnosis of mild platelet function disorders. Reliability and usefulness of light transmission platelet aggregation and serotonin secretion assays","volume":"147","author":"Quiroga","year":"2009","journal-title":"Br. J. Haematol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/bjh.12827","article-title":"Gender, race and diet affect platelet function tests in normal subjects, contributing to a high rate of abnormal results","volume":"165","author":"Miller","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5858\/2002-126-0133-TLDOPD","article-title":"The laboratory diagnosis of platelet disorders","volume":"126","author":"Corcoran","year":"2002","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/FTD.0b013e3182052ff4","article-title":"Light transmittance aggregometry induced by different concentrations of adenosine diphosphate to monitor clopidogrel therapy: A methodological study","volume":"33","author":"Paniccia","year":"2011","journal-title":"Ther. Drug Monit."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/09537104.2011.596592","article-title":"Comparison of different procedures to prepare platelet-rich plasma for studies of platelet aggregation by light transmission aggregometry","volume":"23","author":"Femia","year":"2012","journal-title":"Platelets"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/jth.12231","article-title":"Recommendations for the standardization of light transmission aggregometry: A consensus of the working party from the Platelet Physiology Subcommittee of SSC\/ISTH","volume":"11","author":"Cattaneo","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"ref_47","unstructured":"Christie, D.J., Avari, T., Carrington, L.R., Cohen, E., DeBiase, B.A., Harrison, P., Kickler, T.S., Kottke-Marchant, K., Ledford-Kraemer, M., and Rand, M.L. (2008). Platelet Function Testing by Aggregometry; Approved Guideline, Clinical and Laboratory Standards Institute."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2141.2011.08793.x","article-title":"British Committee for Standards in Haematology. Guidelines for the laboratory investigation of heritable disorders of platelet function","volume":"155","author":"Harrison","year":"2011","journal-title":"Br. J. Haematol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.thromres.2005.10.011","article-title":"Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: A 6 months prospective study","volume":"118","author":"Gianetti","year":"2006","journal-title":"Thromb. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ahj.2006.10.040","article-title":"Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review","volume":"153","author":"Hovens","year":"2007","journal-title":"Am. Heart J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.amjcard.2006.05.041","article-title":"Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events","volume":"98","author":"Marcucci","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1538-7836.2008.02897.x","article-title":"Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: A systematic review and meta-analysis","volume":"6","author":"Reny","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1160\/TH08-03-0198","article-title":"Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review","volume":"99","author":"Crescente","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1160\/TH06-11-0618","article-title":"Residual platelet reactivity is an independent predictor of myocardial injury in acute myocardial infarction patients on antiaggregant therapy","volume":"98","author":"Marcucci","year":"2007","journal-title":"Thromb. Haemost."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1161\/01.STR.0000162719.11058.bd","article-title":"Screening for aspirin responsiveness after transient ischemic attack and stroke: Comparison of 2 point-of-care platelet function tests with optical aggregometry","volume":"36","author":"Harrison","year":"2005","journal-title":"Stroke"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/09537104.2011.601361","article-title":"Evaluation of the INNOVANCE PFA P2Y test cartridge: Sensitivity to P2Y(12) blockade and influence of anticoagulant","volume":"23","author":"Edwards","year":"2012","journal-title":"Platelets"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2005.05511.x","article-title":"The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults","volume":"130","author":"Harrison","year":"2005","journal-title":"Br. J. Haematol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1538-7836.2006.01771.x","article-title":"Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function","volume":"4","author":"Hayward","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0037-1613805","article-title":"Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100","volume":"83","author":"Homoncik","year":"2000","journal-title":"Thromb. Haemost."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/107602960401000206","article-title":"A practical concept for preoperative management of patients with impaired primary hemostasis","volume":"10","author":"Koscielny","year":"2004","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5482\/ha-1133","article-title":"Platelet function testing in clinical diagnostics","volume":"31","author":"Rechner","year":"2011","journal-title":"Hamostaseologie"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1067\/mtc.2001.114344","article-title":"Clinical utility of the platelet function analyzer (PFA-100) in cardiothoracic procedures involving extracorporeal circulation","volume":"122","author":"Raman","year":"2001","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1213\/00000539-200301000-00011","article-title":"The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery","volume":"96","author":"Cammerer","year":"2003","journal-title":"Anesth. Analg."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.athoracsur.2011.01.052","article-title":"Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion","volume":"91","author":"Steinlechner","year":"2011","journal-title":"Ann. Thorac. Surg."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-0030-1250375","article-title":"Platelet function analyzer (PFA-100) as a useful tool for the prediction of transfusion requirements during aortic valve replacement","volume":"59","author":"Sucker","year":"2011","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/j.1538-7836.2008.03168.x","article-title":"Some hemostasis variables at the end of the population distributions are risk factors for severe postpartum hemorrhages","volume":"6","author":"Chauleur","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2516.2005.01129.x","article-title":"Screening women with menorrhagia for underlying bleeding disorders: The utility of the platelet function analyser and bleeding time","volume":"11","author":"Philipp","year":"2005","journal-title":"Haemophilia"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0160-5402(80)90024-8","article-title":"The electronic aggregometer: A novel device for assessing platelet behavior in blood","volume":"3","author":"Cardinal","year":"1980","journal-title":"J. Pharmacol. Methods"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jcp.37.8.874","article-title":"Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs","volume":"37","author":"Mackie","year":"1984","journal-title":"J. Clin. Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1160\/TH06-05-0242","article-title":"Multiple electrode aggregometry: A new device to measure platelet aggregation in whole blood","volume":"96","author":"Calatzis","year":"2006","journal-title":"Thromb. Haemost."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1309\/AJCPTE3K1SGAPOIZ","article-title":"Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy","volume":"131","author":"Paniccia","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_72","first-page":"287","article-title":"Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients","volume":"104","author":"Paniccia","year":"2010","journal-title":"Thromb. Haemost."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2008.11.030","article-title":"Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis","volume":"53","author":"Sibbing","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1160\/TH09-05-0284","article-title":"Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting","volume":"103","author":"Sibbing","year":"2010","journal-title":"Thromb. Haemost."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.jacc.2013.07.101","article-title":"Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding","volume":"62","author":"Tantry","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.athoracsur.2010.09.022","article-title":"Surgical and Clinical Outcome Research (SCORE) Group Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines","volume":"91","author":"Ranucci","year":"2011","journal-title":"Ann. Thorac. Surg."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1399-6576.2008.01845.x","article-title":"Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry","volume":"53","author":"Winterhalter","year":"2009","journal-title":"Acta Anaesthesiol. Scand."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1053\/j.jvca.2013.05.014","article-title":"Management of hemorrhage in cardiothoracic surgery","volume":"27","author":"Dirkmann","year":"2013","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.jocn.2013.02.022","article-title":"Multiple electrode aggregometry in antiplatelet-related intracerebral haemorrhage","volume":"20","author":"Beynon","year":"2013","journal-title":"J. Clin. Neurosci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1538-7836.2009.03709.x","article-title":"Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement","volume":"8","author":"Sibbing","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2257.2005.00681.x","article-title":"Thrombelastography\/thromboelastometry","volume":"27","author":"Luddington","year":"2005","journal-title":"Clin. Lab. Haematol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1213\/ane.0b013e318168b367","article-title":"Coagulation monitoring: Current techniques and clinical use of viscoelastic point-of-care coagulation devices","volume":"106","author":"Ganter","year":"2008","journal-title":"Anesth. Analg."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tmrv.2013.08.004","article-title":"Roles of thrombelastography and thromboelastometry for patient blood management in cardiac surgery","volume":"27","author":"Bolliger","year":"2013","journal-title":"Transfus. Med. Rev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/bja\/aes374","article-title":"Fast interpretation of thromboelastometry in non-cardiac surgery: Reliability in patients with hypo-, normo-, and hypercoagulability","volume":"110","author":"Dirkmann","year":"2013","journal-title":"Br. J. Anaesth."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/aas.12040","article-title":"Early thromboelastometric variables reliably predict maximum clot firmness in patients undergoing cardiac surgery: A step towards earlier decision making","volume":"57","author":"Dirkmann","year":"2013","journal-title":"Acta Anaesthesiol. Scand."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/j.jvca.2005.04.013","article-title":"The kaolin-activated Thrombelastograph predicts bleeding after cardiac surgery","volume":"20","author":"Welsby","year":"2006","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1160\/TH11-02-0058","article-title":"Reference values for rotation thromboelastometry (ROTEM\u00ae) parameters following non-haemorrhagic deliveries. Correlations with standard haemostasis parameters","volume":"106","author":"Oudghiri","year":"2011","journal-title":"Thromb. Haemost."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijoa.2011.05.004","article-title":"Assessment of coagulation in the obstetric population using ROTEM\u00ae thromboelastometry","volume":"20","author":"Armstrong","year":"2011","journal-title":"Int. J. Obstet. Anesth."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/anae.12859","article-title":"Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage","volume":"70","author":"Mallaiah","year":"2015","journal-title":"Anaesthesia"},{"key":"ref_90","first-page":"CD007871","article-title":"Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion","volume":"3","author":"Afshari","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1053\/j.jvca.2012.06.015","article-title":"Rotational thromboelastometry (ROTEM)-based coagulation management in cardiac surgery and major trauma","volume":"26","author":"Tanaka","year":"2012","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/bja\/aet325","article-title":"Five-minute parameter of thromboelastometry is sufficient to detect thrombocytopenia and hypofibrinogenaemia in patients undergoing liver transplantation","volume":"112","author":"Song","year":"2014","journal-title":"Br. J. Anaesth."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/j.transproceed.2010.05.144","article-title":"Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: Randomized clinical trial","volume":"42","author":"Wang","year":"2010","journal-title":"Transplant. Proc."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11239-012-0788-5","article-title":"Perioperative assessment of platelet function by Thromboelastograph Platelet Mapping in cardiovascular patients undergoing non-cardiac surgery","volume":"35","author":"Cattano","year":"2013","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1213\/ANE.0000000000001507","article-title":"Comparison of SEER Sonorheometry With Rotational Thromboelastometry and Laboratory Parameters in Cardiac Surgery","volume":"123","author":"Huffmyer","year":"2016","journal-title":"Anesth. Analg."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s12098-013-1152-2","article-title":"Flow cytometry in hematological disorders","volume":"80","author":"Pati","year":"2013","journal-title":"Indian J. Pediatr."},{"key":"ref_97","first-page":"88","article-title":"Cytofluorimetric platelet analysis","volume":"40","author":"Carubbi","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000093547","article-title":"Evaluation of platelet function by flow cytometry","volume":"35","author":"Michelson","year":"2006","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0735-1097(01)01485-1","article-title":"Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction","volume":"38","author":"Furman","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/ATVBAHA.111.244616","article-title":"High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles\u2013brief report","volume":"32","author":"Robert","year":"2012","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1111\/j.1538-7836.2005.01603.x","article-title":"Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity","volume":"3","author":"Barnard","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1055\/s-0037-1614050","article-title":"GPIIb-IIIa antagonist-induced reduction in platelet surface factor V\/Va binding and phosphatidylserine expression in whole blood","volume":"84","author":"Furman","year":"2000","journal-title":"Thromb. Haemost."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1111\/jth.12670","article-title":"Multiplexed phosphospecific flow cytometry enables large-scale signaling profiling and drug screening in blood platelets","volume":"12","author":"Spurgeon","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1538-7836.2004.01063.x","article-title":"Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases","volume":"3","author":"Aleil","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.thromres.2014.02.018","article-title":"Global thrombosis test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential","volume":"133","author":"Yamamoto","year":"2014","journal-title":"Thromb. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF01931360","article-title":"Ueber einen neuen formbestandtheil des blutes und dessen rolle bei der thrombose und der blutgerinnung","volume":"90","author":"Bizzozero","year":"1882","journal-title":"Virchows. Arch. Pathol. Anat. Physiol. Klinish. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/10739680590925664","article-title":"Microvascular thrombosis models in venules and arterioles in vivo","volume":"12","author":"Rumbaut","year":"2005","journal-title":"Microcirculation"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/10739680490425949","article-title":"Mouse cremaster venules are predisposed to light\/dye-induced thrombosis independent of wall shear rate, CD18, ICAM-1, or P-selectin","volume":"11","author":"Rumbaut","year":"2004","journal-title":"Microcirculation"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-0038-1642559","article-title":"Thromboembolic reaction following wall puncture in arterioles and venules of the rabbit mesentery","volume":"59","author":"Tangelder","year":"1988","journal-title":"Thromb. Haemost."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/nm782","article-title":"Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse","volume":"8","author":"Falati","year":"2002","journal-title":"Nat. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/10739680701653517","article-title":"Key role of platelet procoagulant activity in tissue factor-and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition","volume":"15","author":"Kuijpers","year":"2008","journal-title":"Microcirculation"},{"key":"ref_112","first-page":"148","article-title":"An ultrastructural analysis of endothelial change paralleling platelet aggregation in a light\/dye model of microvascular insult","volume":"110","author":"Povlishock","year":"1983","journal-title":"Am. J. Pathol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1160\/TH07-05-0324","article-title":"The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis","volume":"98","author":"Blindt","year":"2007","journal-title":"Thromb. Haemost."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1538-7836.2007.02609.x","article-title":"Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events","volume":"5","author":"Bonello","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2010.181","article-title":"Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation","volume":"303","author":"Breet","year":"2010","journal-title":"JAMA"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.jacc.2007.01.094","article-title":"Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis","volume":"49","author":"Buonamici","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.amjcard.2009.06.007","article-title":"Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients","volume":"104","author":"Cuisset","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jacc.2006.06.065","article-title":"Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement","volume":"48","author":"Hochholzer","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/eurheartj\/ehp402","article-title":"Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions","volume":"31","author":"Geisler","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jacc.2008.05.032","article-title":"Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents","volume":"52","author":"Gori","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1161\/CIRCULATIONAHA.109.883454","article-title":"High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drug-eluting stenting for unprotected left main coronary disease","volume":"120","author":"Migliorini","year":"2009","journal-title":"Circulation"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCULATIONAHA.108.812636","article-title":"Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: A 12-month follow-up","volume":"119","author":"Marcucci","year":"2009","journal-title":"Circulation"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/eurheartj\/ehn046","article-title":"Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation","volume":"29","author":"Price","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1538-7836.2009.03699.x","article-title":"Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay","volume":"8","author":"Christ","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1556\/OH.2015.30057","article-title":"Clopidogrel resistance in cerebrovascular disease-results of one-year follow-up","volume":"156","author":"Koltai","year":"2015","journal-title":"Orv. Hetil."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.jacc.2010.12.047","article-title":"Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome","volume":"57","author":"Campo","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jtcvs.2004.02.019","article-title":"Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting","volume":"128","author":"Chen","year":"2004","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4244\/51","article-title":"Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment?","volume":"5","author":"Cuisset","year":"2009","journal-title":"EuroIntervention"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/eurheartj\/ehp159","article-title":"TRITON-TIMI 38 Investigators. Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial","volume":"30","author":"Michelson","year":"2009","journal-title":"Eur. Heart J."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.thromres.2010.01.013","article-title":"Relationship between platelet reactivity inhibition and non-CABG related major bleeding in patients undergoing percutaneous coronary intervention","volume":"126","author":"Mokhtar","year":"2010","journal-title":"Thromb. Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.amjcard.2011.08.034","article-title":"Residual platelet reactivity, bleedings, and adherence to treatment in patients having coronary stent implantation treated with prasugrel","volume":"109","author":"Parodi","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2012.04639.x","article-title":"Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: The PEGASUS-PCI study","volume":"10","author":"Lang","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3174\/ajnr.A3418","article-title":"Clopidogrel hyper-response and bleeding risk in neurointerventional procedures","volume":"34","author":"Goh","year":"2013","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3174\/ajnr.A3405","article-title":"Clopidogrel resistance is associated with thromboembolic complications in patients undergoing neurovascular stenting","volume":"34","author":"Fifi","year":"2013","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/neurintsurg-2015-011727","article-title":"Relationship between low response to clopidogrel and periprocedural ischemic events with coil embolization for intracranial aneurysms","volume":"8","author":"Asai","year":"2016","journal-title":"J. Neurointerv. Surg."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jcin.2008.09.004","article-title":"Clopidogrel 150 mg\/day to overcome low responsiveness in patients undergoing elective percutaneous coronary intervention: Results from the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) randomized study","volume":"1","author":"Aleil","year":"2008","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jacc.2007.12.044","article-title":"Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: A multicenter randomized prospective study","volume":"51","author":"Bonello","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jcin.2008.08.018","article-title":"Glycoprotein IIb\/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: A prospective, randomized study","volume":"1","author":"Cuisset","year":"2008","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jcin.2008.09.005","article-title":"The antiplatelet effect of higher loading and maintenance dose regimens of clopidogrel: The PRINC (Plavix Response in Coronary Intervention) trial","volume":"1","author":"Gladding","year":"2008","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10557-008-6121-z","article-title":"Tailoring treatment with tirofiban in patients showing resistance to aspirin and\/or resistance to clopidogrel (3T\/2R). Rationale for the study and protocol design","volume":"22","author":"Valgimigli","year":"2008","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijcard.2008.02.016","article-title":"The clopidogrel resistance can be attenuated with triple antiplatelet therapy in patients undergoing drug-eluting stents implantation","volume":"134","author":"Shim","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1161\/CIRCULATIONAHA.108.833236","article-title":"Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and\/or Resistance to Clopidogrel (3T\/2R) Investigators. Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and\/or resistance to clopidogrel study","volume":"119","author":"Valgimigli","year":"2009","journal-title":"Circulation"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jacc.2009.08.052","article-title":"Evaluation of platelet inhibition by tirofiban in patients stratified according to aspirin and clopidogrel responsiveness: The 3T\/2R (Tailoring treatment with tirofiban in patients showing resistance to aspirin and\/or resistance to clopidogrel)","volume":"55","author":"Campo","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijcard.2010.12.083","article-title":"The EFFect of high-dose ClopIdogrel treatmENT in patients with clopidogrel resistance (The EFFICIENT trial)","volume":"157","author":"Ari","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/CIRCULATIONAHA.111.029165","article-title":"Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: A time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial","volume":"124","author":"Price","year":"2011","journal-title":"Circulation"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2012.02.026","article-title":"A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: Results of the TRIGGER-PCI (Testing Platelet Reactivity in Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study","volume":"59","author":"Trenk","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ahj.2010.09.029","article-title":"Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: Rationale and design of the assessment with a double randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and clopidogrel after DES implantation, and (2) treatment interruption versus continuation, 1 year after stenting (ARCTIC) study","volume":"161","author":"Collet","year":"2011","journal-title":"Am. Heart J."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(16)31323-X","article-title":"Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): An open-label, blinded-endpoint, randomised controlled superiority trial","volume":"388","author":"Cayla","year":"2016","journal-title":"Lancet"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.amjcard.2017.02.033","article-title":"Effect of Tailored Antiplatelet Therapy to Reduce Recurrent Stent Thrombosis and Cardiac Death After a First Episode of Stent Thrombosis","volume":"119","author":"Godschalk","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1160\/TH16-07-0557","article-title":"A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial","volume":"117","author":"Sibbing","year":"2017","journal-title":"Thromb. Haemost."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Aoun, S.G., Welch, B.G., Pride, L.G., White, J., Novakovic, R., Hoes, K., and Sarode, R. (2016). Contribution of whole platelet aggregometry to the endovascular management of unruptured aneurysms: An institutional experience. J. Neurointerv. Surg.","DOI":"10.1136\/neurintsurg-2016-012623"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/8\/1803\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:42:45Z","timestamp":1760208165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/8\/1803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,18]]},"references-count":151,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8]]}},"alternative-id":["ijms18081803"],"URL":"https:\/\/doi.org\/10.3390\/ijms18081803","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,18]]}}}